-
HIV/AIDS - Research and Palliative Care
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Novel mechanisms of central nervous system damage in HIV infection
Review
(2517) Views (1230) Full article downloads
Authors: Joy E Hazleton, Joan W Berman, Eliseo A Eugenin
Published Date March 2010
Volume 2010:2 Pages 39 - 49
DOI: http://dx.doi.org/10.2147/HIV.S9186
Joy E Hazleton1, Joan W Berman1,2, Eliseo A Eugenin1
1Department of Pathology and 2Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA
Abstract: Human immunodeficiency virus-1 infection of the central nervous system is an early event after primary infection, resulting in motor and cognitive defects in a significant number of individuals despite successful antiretroviral therapy. The pathology of the infected brain is characterized by enhanced leukocyte infiltration, microglial activation and nodules, aberrant expression of inflammatory factors, neuronal dysregulation and loss, and blood–brain barrier disruption. Months to years following the primary infection, these central nervous system insults result in a spectrum of motor and cognitive dysfunction, ranging from mild impairment to frank dementia. The mechanisms that mediate impairment are still not fully defined. In this review we discuss the cellular and molecular mechanisms that facilitate impairment and new data that implicate intercellular communication systems, gap junctions and tunneling nanotubes, as mediators of human immunodeficiency virus-1 toxicity and infection within the central nervous system. These data suggest potential targets for novel therapeutics.
Keywords: AIDS, dementia, inflammation, gap junctions, nanotubes, chemokines
Readers of this article also read:
Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
Effect of HIV infection on time to recovery from an acute manic episode
Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells
Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?
Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy
Osteopenia and osteoporosis in people living with HIV: multiprofessional approach
The use of preexposure treatments for HIV prophylaxis
- Interested in being a peer-reviewer?
Click here to register.
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi
- Treatment of drug-resistant tuberculosis
- Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
- High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India




